P2 receptor expression, signaling and function in osteoclasts

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 3, 2011, Pages 1101-1118

  Reyes, Juan P ^a   Sims, Stephen M ^a   Dixon, S Jeffrey ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Apoptosis; ATP; Bone; Calcium; Calciumactivated potassium channels; Electrophysiology; Ion channel; NF B; Nucleotide; Osteoclastogenesis; Osteoclasts; P2 receptors; P2X receptors; P2X7; P2Y receptors; Patch clamp; Protein kinase C; Purinergic; Resorption; Review; Signaling; Survival

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM; ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCENT DYE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PURINERGIC P2 RECEPTOR; PURINERGIC P2X RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ACTIN FILAMENT; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL COMMUNICATION; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CELL MIGRATION; CELL PERMEABILIZATION; CELL STIMULATION; CELL SURVIVAL; CONFORMATIONAL TRANSITION; CYTOFLUOROMETRY; CYTOLYSIS; DNA POLYMORPHISM; ELECTROPHYSIOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRACELLULAR SIGNALING; MECHANICAL STIMULATION; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BONE DEVELOPMENT; BONE REMODELING; CYTOSKELETON; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; PERMEABILITY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BONE DEVELOPMENT; BONE REMODELING; CALCIUM; CELL MEMBRANE; CYTOSKELETON; GENE EXPRESSION REGULATION; HUMANS; MICE; NF-KAPPA B; OSTEOCLASTS; PERMEABILITY; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 80053125171     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. S. L. Teitelbaum: Bone resorption by osteoclasts. Science 289, 1504-1508 (2000)
2. Leibbrandt and J. M. Penninger: RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. Adv Exp Med Biol 649, 100-113 (2009)
3. J. M. Quinn, J. Elliott, M. T. Gillespie and T. J. Martin: A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139, 4424-4427 (1998) (Pubitemid 28513734)
4. G. Franzoso, L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce and U. Siebenlist: Requirement for NF-κB in osteoclast and B-cell development. Genes Dev 11, 3482-3496 (1997) (Pubitemid 28023969)
5. V. Iotsova, J. Caamano, J. Loy, Y. Yang, A. Lewin and R. Bravo: Osteopetrosis in mice lacking NF-κB1 and NF- κB2. Nat Med 3, 1285-1289 (1997)
6. T. J. Chambers and C. J. Magnus: Calcitonin alters behaviour of isolated osteoclasts. J Pathol 136, 27-39 (1982) (Pubitemid 12213616)
7. M. F. Pilkington, S. M. Sims and S. J. Dixon: Wortmannin inhibitsspreading and chemotaxis of rat osteoclasts in vitro. J Bone Miner Res 13, 688-694 (1998) (Pubitemid 28163020)
8. L. Espinosa, L. Paret, C. Ojeda, Y. Tourneur, P. D. Delmas and C. Chenu: Osteoclast spreadingkinetics are correlated with an oscillatory activation of a calciumdependent potassium current. J Cell Sci 115, 3837-3848 (2002) (Pubitemid 35203610)
9. D. Chodniewicz and R. L. Klemke: Guiding cell migration through directed extension and stabilization of pseudopodia. Exp Cell Res 301, 31-37 (2004) (Pubitemid 39388893)
10. Zambonin Zallone, A. Teti, M. Gaboli and P. C. Marchisio: Beta3 subunit of vitronectin receptor is present in osteoclast adhesion structures and not in other monocytemacrophage derived cells. Connect Tissue Res 20, 143-149 (1989)
11. M. A. Horton, M. L. Taylor, T. R. Arnett and M. H. Helfrich: Arg-Gly-Asp ( RGD) peptides and the antivitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 195, 368-375 (1991) (Pubitemid 121006336)
12. M. A. Horton, E. L. Dorey, S. A. Nesbitt, J. Samanen, F. E. Ali, J. M. Stadel, A. Nichols, R. Greig and M. H. Helfrich: Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis. J Bone Miner Res 8, 239-247 (1993) (Pubitemid 23060642)
13. K. P. McHugh, K. Hodivala-Dilke, M. H. Zheng, N. Namba, J. Lam, D. Novack, X. Feng, F. P. Ross, R. O. Hynes and S. L. Teitelbaum: Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105, 433-440 (2000) (Pubitemid 30127243)
14. X. Feng, D. V. Novack, R. Faccio, D. S. Ory, K. Aya, M. I. Boyer, K. P. McHugh, F. P. Ross and S. L. Teitelbaum: A Glanzmann's mutation in β3 integrin specifically impairs osteoclast function. J Clin Invest 107, 1137-1144 (2001) (Pubitemid 32422910)
15. M. F. Pilkington, S. M. Sims and S. J. Dixon: Transforming growth factor-β induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment. J Bone Miner Res 16, 1237-1247 (2001) (Pubitemid 32574652)
16. K. Fuller, J. M. Owens, C. J. Jagger, A. Wilson, R. Moss and T. J. Chambers: Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178, 1733-1744 (1993) (Pubitemid 23318452)
17. T. J. Chambers, P. A. Revell, K. Fuller and N. A. Athanasou: Resorption of bone by isolated rabbit osteoclasts. J Cell Sci 66, 383-399 (1984) (Pubitemid 14051778)
18. Z. Bar-Shavit: The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem 102, 1130-1139 (2007) (Pubitemid 350220034)
19. D. V. Novack and S. L. Teitelbaum: The osteoclast: friend or foe? Annu Rev Pathol 3, 457-484 (2008) (Pubitemid 351488289)
20. S. C. Manolagas: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21, 115-137 (2000) (Pubitemid 32275592)
21. D. E. Hughes, K. R. Wright, H. L. Uy, A. Sasaki, T. Yoneda, G. D. Roodman, G. R. Mundy and B. F. Boyce: Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10, 1478-1487 (1995)
22. K. Ozaki, H. Takeda, H. Iwahashi, S. Kitano and S. Hanazawa: NF-κB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells. FEBS Lett 410, 297-300 (1997) (Pubitemid 27304083)
23. L. Penolazzi, E. Lambertini, M. Borgatti, R. Piva, M. Cozzani, I. Giovannini, R. Naccari, G. Siciliani and R. Gambari: Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts. Biochem Pharmacol 66, 1189-1198 (2003) (Pubitemid 37130294)
24. V. Ralevic and G. Burnstock: Receptors for purines and pyrimidines. Pharmacol Rev 50, 413-492 (1998) (Pubitemid 28477681)
25. L. N. Naemsch, X. B. Du, S. M. Sims and S. J. Dixon: P2 nucleotide receptors in osteoclasts. Drug Dev Res 53, 130-139 (2001) (Pubitemid 32845852)
26. I. R. Orriss, G. Burnstock and T. R. Arnett: Purinergic signalling and bone remodelling. Curr Opin Pharmacol 10, 322-330 (2010)
27. M. W. Grol, N. Panupinthu, J. Korcok, S. M. Sims and S. J. Dixon: Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal 5, 205-221 (2009)
28. R. A. North: Molecular physiology of P2X receptors. Physiol Rev 82, 1013-1067 (2002)
29. M. P. Abbracchio, G. Burnstock, J. M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson and G. A. Weisman: International Union of P harmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58, 281-341 (2006) (Pubitemid 44394905)
30. G. Burnstock: Purine and pyrimidine receptors. Cell Mol Life Sci 64, 1471-1483 (2007) (Pubitemid 46954150)
31. G. Burnstock: Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87, 659-797 (2007) (Pubitemid 47084682)
32. T. Kawate, J. C. Michel, W. T. Birdsong and E. Gouaux: Crystal structure of the ATP-gated P2X4 ion channel in the closed state. Nature 460, 592-598 (2009)
33. L. N. Naemsch, A. F. Weidema, S. M. Sims, T. M. Underhill and S. J. Dixon: P2X4 purinoceptors mediate an ATP-activated, non-selective cation current in rabbit osteoclasts. J Cell Sci 112, 4425-4435 (1999) (Pubitemid 30122034)
34. L. N. Naemsch, S. J. Dixon and S. M. Sims: Activity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts. J Biol Chem 276, 39107-39114 (2001)
35. A. Hoebertz, A. Townsend-Nicholson, R. Glass, G. Burnstock and T. R. Arnett: Expression of P2 receptors in bone and cultured bone cells. Bone 27, 503-510 (2000)
36. M. Boumechache, M. Masin, J. M. Edwardson, D. C. Gorecki and R. Murrell-Lagnado: Analysis of assembly and trafficking of native P2X4 and P2X7 receptor complexes in rodent immune cells. J Biol Chem 284, 13446-13454 (2009)
37. A. F. Weidema, J. Barbera, S. J. Dixon and S. M. Sims: Extracellular nucleotides activate non-selective cation and Ca2+-dependent K+ channels in rat osteoclasts. J Physiol 503, 303-315 (1997) (Pubitemid 27423357)
38. G. Buell, C. Lewis, G. Collo, R. A. North and A. Surprenant: An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J 15, 55-62 (1996)
39. G. Casas-Pruneda, J. P. Reyes, G. Perez-Flores, P. Perez-Cornejo and J. Arreola: Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia. J Physiol 587, 2887-2901 (2009)
40. R. A. North and A. Surprenant: Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40, 563-580 (2000) (Pubitemid 30340693)
41. I. Xiong, R. W. Peoples, J. P. Montgomery, Y. Chiang, R. R. Stewart, F. F. Weight and C. Li: Differentialmodulation by copper and zinc of P2X2 and P2X4 receptor function. J Neurophysiol 81, 2088-2094 (1999) (Pubitemid 29262543)
42. I. J. Miller, A. D. Michel, I. P. Chessell and P. P. Humphrey: Cibacron blue allosterically modulates the rat P2X4 receptor. Neuropharmacology 37, 1579-1586 (1998) (Pubitemid 28550431)
43. A. F. Weidema, S. J. Dixon and S. M. Sims: Activation of P2Y but not P2X4 nucleotide receptors causes elevation of [Ca2+]i in mammalian osteoclasts. Am J Physiol Cell Physiol 280, C1531-1539 (2001)
44. I. von Kugelgen: Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110, 415-432 (2006)
45. F. Soto, M. Garcia-Guzman, J. M. Gomez-Hernandez, M. Hollmann, C. Karschin and W. Stuhmer: P2X4: an ATP-activated ionotropic receptor cloned from rat brain. Proc Natl Acad Sci USA 93, 3684-3688 (1996) (Pubitemid 26125674)
46. I. A. Buckley, R. A. Hipskind, A. Gartland, W. B. Bowler and J. A. Gallagher: Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor- κB ligand. Bone 31, 582-590 (2002) (Pubitemid 35449700)
47. N. R. Jørgensen, Z. Henriksen, O. H. Sørensen, E. F. Eriksen, R. Civitelli and T. H. Steinberg: Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors. J Biol Chem 277, 7574-7580 (2002) (Pubitemid 34953156)
48. A. Gartland, K. A. Buckley, W. B. Bowler and J. A. Gallagher: Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif Tissue Int 73, 361-369 (2003) (Pubitemid 37409423)
49. I. Penolazzi, E. Bianchini, E. Lambertini, P. G. Baraldi, R. Romagnoli, R. Piva and R. Gambari: NArylpiperazine modified analogues of the P2X7 receptor KN-62 antagonist are potent inducers of apoptosis of human primary osteoclasts. J Biomed Sci 12, 1013-1020 (2005) (Pubitemid 43081680)
50. R. Hazama, X. Qu, K. Yokoyama, C. Tanaka, E. Kinoshita, J. He, S. Takahashi, K. Tohyama, H. Yamamura and Y. Tohyama: ATP-induced osteoclast function: the formation of sealing-zone like structure and the secretion of lytic granules via microtubuledeacetylation under the control of Syk. Genes Cells 14, 871-884 (2009)
51. A. Surprenant, F. Rassendren, E. Kawashima, R. A. North and G. Buell: The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272, 735-738 (1996)
52. A. D. Hibell, E. J. Kidd, I. P. Chessell, P. P. Humphrey and A. D. Michel: Apparent species differences in the kinetic properties of P2X7 receptors. Br J Pharmacol 130, 167-173 (2000) (Pubitemid 30248441)
53. A. Virginio, D. Church, R. A. North and A. Surprenant: Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 36, 1285-1294 (1997) (Pubitemid 27465616)
54. H. Z. Ke, H. Qi, A. F. Weidema, Q. Zhang, N. Panupinthu, D. T. Crawford, W. A. Grasser, V. M. Paralkar, M. Li, L. P. Audoly, C. A. Gabel, W. S. Jee, S. J. D ixon, S. M. Sims and D. D. Thompson: Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol 17, 1356-1367 (2003) (Pubitemid 36819956)
55. T. Pannicke, W. Fischer, B. Biedermann, H. Schädlich, J. Grosche, F. Faude, P. Wiedemann, C. Allgaier, P. Illes, G. Burnstock and A. Reichenbach: P2X7 receptors in Müller glial cells from the human retina. J Neurosci 20, 5965-5972 (2000) (Pubitemid 30658388)
56. A. N. Ramirez and D. L. Kunze: P2X purinergic receptor channel expression and function in bovine aortic endothelium. Am J Physiol Heart Circ Physiol 282, H2106-2116 (2002) (Pubitemid 34663020)
57. T. Watano, I. Matsuoka and J. Kimura: Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation. Jpn J Pharmacol 88, 428-435 (2002) (Pubitemid 34516569)
58. W. E. Modderman, A. F. Weidema, T. Vrijheid-Lammers, A. M. Wassenaar and P. J. Nijweide: Permeabilization of cells of hemopoietic origin by extracellular ATP4-: elimination of osteoclasts, macrophages, and their precursors from isolated bone cell populations and fetal bone rudiments. Calcif Tissue Int 55, 141-150 (1994) (Pubitemid 24237537)
59. J. F. Hiken and T. H. Steinberg: ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells. Am J Physiol Cell Physiol 287, C403-412 (2004) (Pubitemid 38955231)
60. S. Armstrong, A. Pereverzev, S. J. Dixon and S. M. Sims: Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts. J Cell Sci 122, 136-144 (2009)
61. S. Armstrong, J. Korcok, S. M. Sims and S. J. Dixon: Activation of transcription factors by extracellular nucleotides in immune and related cell types. Purinergic Signal 3, 59-69 (2007)
62. J. Korcok, L. N. Raimundo, H. Z. Ke, S. M. Sims and S. J. Dixon: Extracellular nucleotides act through P2X7 receptors to activate NF-κB in osteoclasts. J Bone Miner Res 19, 642-651 (2004) (Pubitemid 41071225)
63. P. Chiozzi, J. M. Sanz, D. Ferrari, S. Falzoni, A. Aleotti, G. N. Buell, G. Collo and F. Di Virgilio: Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. J Cell Biol 138, 697-706 (1997) (Pubitemid 27349848)
64. A. Agrawal, K. A. Buckley, K. Bowers, M. Furber, J. A. Gallagher and A. Gartland: The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro. Purinergic Signal 6, 307-315 (2010)
65. A. Gartland, K. A. Buckley, R. A. Hipskind, M. J. Perry, J. H. Tobias, G. Buell, I. Chessell, W. B. Bowler and J. A. Gallagher: Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice. Crit Rev Eukaryot Gene Expr 13, 243-253 (2003) (Pubitemid 38009173)
66. I. J. Raggatt and N. C. Partridge: Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285, 25103-25108 (2010)
67. S. Armstrong, A. Pereverzev, E. Kwon, S. J. Dixon and S. M. Sims: Activation of P2X7 nucleotide receptors induces actin reorganization in osteoclasts. Eur Cells Mat 16, 42 (2008)
68. A. Cario-Toumaniantz, G. Loirand, L. Ferrier and P. Pacaud: Non-genomic inhibition of human P2X7 purinoceptor by 17β-oestradiol. J Physiol 508, 659-666 (1998) (Pubitemid 28220722)
69. G. I. Gorodeski : Estrogen attenuates P2X7-R-mediated apoptosis of uterine cervical cells by blocking calcium influx. Nucleosides Nucleotides Nucleic Acids 23, 1287-1293 (2004) (Pubitemid 39625913)
70. A. Nicke, Y. H. Kuan, M. Masin, J. Rettinger, B. Marquez-Klaka, O. Bender, D. C. Górecki, R. D. Murrell-Lagnado and F. Soto: A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J Biol Chem 284, 25813-25822 (2009)
71. S. R. Taylor, M. Gonzalez-Begne, D. K. Sojka, J. C. Richardson, S. A. Sheardown, S. M. Harrison, C. D. Pusey, F. W. Tam and J. I. Elliott: Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses. J Leukoc Biol 85, 978-986 (2009)
72. J. Li, D. Liu, H. Z. Ke, R. L. Duncan and C. H. Turner: The P2X7 nucleotide receptor mediates skeletal mechanotransduction. J Biol Chem 280, 42952-42959 (2005) (Pubitemid 43049258)
73. N. Panupinthu, J. T. Rogers, L. Zhao, L. P. Solano-Flores, F. Possmayer, S. M. Sims and S. J. Dixon: P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. J Cell Biol 181, 859-871 (2008) (Pubitemid 351786989)
74. A. J. Gu, W. Zhang, R. A. Worthington, R. Sluyter, P. Dao-Ung, S. Petrou, J. A. Barden and J. S. Wiley: A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 276, 11135-11142 (2001) (Pubitemid 38089296)
75. W. Boldt, M. Klapperstück, C. Büttner, S. Sadtler, G. Schmalzing and F. Markwardt: Glu496Ala polymorphism of human P2X7 receptor does not affect its electrophysiological phenotype. Am J Physiol Cell Physiol 284, C749-756 (2003) (Pubitemid 36237527)
76. J. S. Wiley, L. P. Dao-Ung, C. Li, A. N. Shemon, B. J. Gu, M. L. Smart, S. J. Fuller, J. A. Barden, S. Petrou and R. Sluyter: An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 278, 17108-17113 (2003) (Pubitemid 36799588)
77. S. D. Ohlendorff, C. L. Tofteng, J. E. Jensen, S. Petersen, R. Civitelli, M. Fenger, B. Abrahamsen, A. P. Hermann, P. Eiken and N. R. Jørgensen: Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet Genomics 17, 555-567 (2007) (Pubitemid 46905222)
78. A. Wesselius, M. Bours, A. A., A. Gartland, P. Dagnelie, P. Schwarz and N. Jørgensen: Role of purinergic receptor polymorphisms in human bone. Front Biosci (In Press)
79. J. Korcok, L. N. Raimundo, X. Du, S. M. Sims and S. J. Dixon: P2Y6 nucleotide receptors activate NF-κB and increase survival of osteoclasts. J Biol Chem 280, 16909-16915 (2005) (Pubitemid 41389150)
80. H. Yu and J. Ferrier: ATP induces an intracellular calcium pulse in osteoclasts. Biochem Biophys Res Commun 191, 357-363 (1993) (Pubitemid 23222643)
81. H. Yu and J. Ferrier: Mechanisms of ATP-induced Ca2+ signaling in osteoclasts. Cell Signal 6, 905-914 (1994)
82. R. C. Garrad, M. A. Otero, L. Erb, P. M. Theiss, L. L. Clarke, F. A. Gonzalez, J. T. Turner and G. A. Weisman: Structural basis of agonist-induced desensitization and sequestration of the P2Y2 nucleotide receptor. Consequences of truncation of the C terminus. J Biol Chem 273, 29437-29444 (1998) (Pubitemid 28509947)
83. A. F. Weidema, S. J. Dixon and S. M. Sims: Electrophysiological characterization of ion channels in osteoclasts isolated from human deciduous teeth. Bone 27, 5-11 (2000) (Pubitemid 30365071)
84. A. Hoebertz, S. Meghji, G. Burnstock and T. R. Arnett: Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y1 receptor on bone cells. FASEB J 15, 1139-1148 (2001) (Pubitemid 32436299)
85. W. B. Bowler, M. A. Birch, J. A. Gallagher and G. Bilbe: Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts. J Bone Miner Res 10, 1137-1145 (1995)
86. W. B. Bowler, A. Littlewood-Evans, G. Bilbe, J. A. Gallagher and C. J. Dixon: P2Y2 receptors are expressed by human osteoclasts of giant cell tumor but do not mediate ATP-induced bone resorption. Bone 22, 195-200 (1998) (Pubitemid 28127474)
87. S. H. Wiebe, S. M. Sims and S. J. Dixon: Calcium signalling via multiple P2 purinoceptor subtypes in rat osteoclasts. Cell Physiol Biochem 9, 323-337 (1999) (Pubitemid 30021940)
88. W. Pendergast, B. R. Yerxa, J. G. Douglass, 3rd, S. R. Shaver, R. W. Dougherty, C. C. Redick, I. F. Sims and J. L. Rideout: Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates. Bioorg Med Chem Lett 11, 157-160 (2001) (Pubitemid 32099630)
89. M. S. Morrison, L. Turin, B. F. King, G. Burnstock and T. R. Arnett: ATP is a potent stimulator of the activation and formation of rodent osteoclasts. J Physiol 511, 495-500 (1998) (Pubitemid 28444617)
90. S. J. Dixon and S. M. Sims: P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development. Drug Dev Res 49, 187-200 (2000) (Pubitemid 30324635)
91. G. Burnstock and M. Williams: P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 295, 862-869 (2000)
92. J. Korcok, S. M. Sims and S. J. Dixon: P2 nucleotide receptor signaling in osteoclasts. In: Nucleotides and regulation of bone cell function. Eds: G. Burnstock and T. R. Arnett. CRC Press, Boca Raton (2007)